<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Oppenheimer sees stronger growth at Boston Scientific — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Oppenheimer sees stronger growth at Boston Scientific</h2>
    <div class="badge">2025-09-08T16:50:57+00:00</div>
    <ul>
      <li>They forecast annual growth of 11-13%, which was well above the broader medtech sector.</li>
<li>Boston Scientific was upgraded from Perform with a $125 price target.</li>
<li>Coverage of Tandem Diabetes was also assumed with an Outperform rating, though its target price was cut to $22 from $44.</li>
<li>Insulet was reiterated at Outperform and its target price raised to $365 from $324 following second-quarter results.</li>
<li>It could weigh on margins despite strong sales potential.</li>
<li>Investing.com -- Oppenheimer analysts shifted ratings on U.S.</li>
<li>Oppenheimer cited second-quarter performance and valuation adjustments.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Oppenheimer sees stronger growth at Boston Scientific\n• They forecast annual growth of 11-13%, which was well above the broader medtech sector.\n• Boston Scientific was upgraded from Perform with a $125 price target.\n• Coverage of Tandem Diabetes was also assumed with an Outperform rating, though its target price was cut to $22 from $44.\n• Insulet was reiterated at Outperform and its target price raised to $365 from $324 following second-quarter results.\n• It could weigh on margins despite strong sales potential.\n• Investing.com -- Oppenheimer analysts shifted ratings on U.S.\n• Oppenheimer cited second-quarter performance and valuation adjustments." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/oppenheimer-sees-stronger-growth-boston-165057851.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>